Details of the Drug
General Information of Drug (ID: DMEVK5F)
| Drug Name |
4,7-dichloro-1H-indole-2,3-dione
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
4,7-Dichloroisatin; 18711-13-2; 4,7-dichloroindoline-2,3-dione; 4,7-dichloro-1H-indole-2,3-dione; 4,7-dichloro isatin; 4,7-dichloro-isatin; 4,7-dichloro-2,3-dihydro-1H-indole-2,3-dione; 1H-Indole-2,3-dione, 4,7-dichloro-; 4,7-dichloroisatin;; 4,7-dichloroisatine;; AC1MC1Y2; Isatin-based compound, 51; ACMC-1C3I3; 4,7-Dichloroisatin, 97%; KSC494I6J; SCHEMBL281619; CHEMBL223039; 4,7-Dichloroindole-2,3-dione; CTK3J4464; BDBM22831; DTXSID90370507; 4,7-Dichloro-2,3-indolinedione; MolPort-001-766-630; 4,7-Dichloroindole-2,3-dione;
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 216.02 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 2 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 0 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | ||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||
|
||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||


